EE662 Cost-Effectiveness of Iron Chelation Therapies for the Treatment of Transfusional Iron Overload in Β-Thalassaemia, Sickle Cell Disease, and Myelodysplastic Syndrome: A Literature Review
Dec 1, 2022, 00:00 AM
10.1016/j.jval.2022.09.901
https://www.valueinhealthjournal.com/article/S1098-3015(22)03105-9/fulltext
Section Title :
Section Order :
10449
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)03105-9&doi=10.1016/j.jval.2022.09.901